Univest
Univest
  • Markets

Medplus Health Services (MEDPLUS) Share Price hits fresh 52-week low as MEDPLUS trades at Rs 611.05

  • October 5, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
MEDPLUS Share Price
Medplus Health Services Ltd. (MEDPLUS) share price fell to a fresh 52-week low of Rs 609.25 today and later stood at Rs 611.05, down 0.26% from the previous close. Market cap was Rs 7,362 crore.

MEDPLUS Share Price is trading at Rs 611.05 after touching a fresh 52-week low of Rs 609.25, down 0.26% on the day. Medplus Health Services Ltd. (MEDPLUS) has a market capitalisation of Rs 7,362 crore, placing the move in the context of a mid-sized retailing business. The price move is confirmed in Univest data; a company-specific reason has not been established.

The latest Univest figures show MEDPLUS Share Price moving between Rs 609.25 and Rs 615.05 after opening at Rs 615.05. The previous close was Rs 612.65, so the stock is trading slightly below that level. For readers tracking MEDPLUS Share Price Today, the main point is simple: the stock has printed a fresh 52-week low and is now trading just above it. Univest data also shows the company’s valuation and operating ratios, which help frame whether this yearly low is occurring in a rich or moderate valuation setup.

Table of Contents

Toggle
  • MEDPLUS Share Price Today: Price Action Analysis
  • Medplus Health Services Ltd. (MEDPLUS) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Medplus Health Services Ltd.
  • About Medplus Health Services Ltd.
  • Track MEDPLUS Share Price on Univest
  • Frequently Asked Questions
    • What is MEDPLUS Share Price today?
    • Why did MEDPLUS touch a fresh 52-week low?
    • What was MEDPLUS’s previous close?
    • What is the 52-week low for MEDPLUS?
    • What is MEDPLUS’s market capitalisation?
    • How does MEDPLUS compare with retail peers?
    • What do MEDPLUS profitability ratios show?
    • Should investors track MEDPLUS Share Price on Univest?

MEDPLUS Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 611.05
Previous Close Rs 612.65
Today's Move Rs -1.6 (-0.26%)
Open Rs 615.05
High Rs 615.05
Low Rs 609.25
Market Capitalisation Rs 7,362 crore

Medplus Health Services Ltd. (MEDPLUS) traded at Rs 611.05 versus the previous close of Rs 612.65, a fall of 0.26%. The stock opened at Rs 615.05, reached a high of Rs 615.05, touched a low of Rs 609.25.

MEDPLUS Share Price Today reflects a narrow intraday range and a modest decline versus the previous close. The stock opened at Rs 615.05, touched a high of Rs 615.05 and a low of Rs 609.25, and last traded at Rs 611.05. The day change is Rs -1.60, equal to -0.26%, versus the previous close of Rs 612.65. For MEDPLUS Share Price watchers, the fresh 52-week low matters because it marks the lowest level seen in the current one-year window, while the current price shows the stock is trading close to that trough. The market capitalisation of Rs 7,362 crore gives additional context to the move. For MEDPLUS Share Price Today, the verified numbers show a weak price backdrop without any unsupported explanation attached to the move.

In MEDPLUS Stock News coverage, the price action is the central fact: a one-year low was printed and the stock is still trading near it. That sets up the next question around MEDPLUS Fundamental Analysis, because valuation and operating ratios help explain how expensive or inexpensive the business looks relative to its retail peers. MEDPLUS Share Price therefore needs to be read with the company’s earnings and balance-sheet metrics rather than only the day’s move.

Medplus Health Services Ltd. (MEDPLUS) Fundamental Analysis

Metric Value
Market Capitalisation Rs 7,362 crore
P/E Ratio 34.97x
P/B Ratio 3.68x
ROE 11.93%
ROCE 22.22%
EPS Rs 17.52
Book Value Per Share Rs 166.52
Dividend Yield 0%

Medplus Health Services Ltd. (MEDPLUS) fundamental metrics show P/E 34.97x, P/B 3.68x, ROE 11.93%, ROCE 22.22%. These ratios show where the company stands today and are not a call to buy or sell.

Medplus Health Services Ltd. has a market capitalisation of Rs 7,362 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 34.97x, P/B at 3.68x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.93% and ROCE of 22.22%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.52, book value per share of Rs 166.52, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 24.2x, median ROE of 12.99%, median ROCE of 18.08%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Retailing
Industry Retailing
Benchmark Scope same industry
Company P/E Ratio 34.97x
Benchmark Median P/E 24.2x
Benchmark Average P/E 65.04x
Benchmark P/E Range 0.93x to 1,443.55x
Company P/B Ratio 3.68x
Benchmark Median P/B 2.52x
Company ROE 11.93%
Benchmark Median ROE 12.99%
Company ROCE 22.22%
Benchmark Median ROCE 18.08%
Company Market Capitalisation Rs 7,362 crore
Benchmark Median Market Cap Rs 195.03 crore

Medplus Health Services Ltd. (MEDPLUS) operates in the Retailing sector, within the Retailing industry.

Medplus Health Services Ltd. (MEDPLUS) has a P/E ratio of 34.97x, which is above the benchmark median of 24.2x, a difference of +44.5%. A P/E difference of this kind is a reference point rather than a recommendation.

Medplus Health Services Ltd. (MEDPLUS) has a ROE of 11.93%, which is below the benchmark median of 12.99%, a difference of -8.16%. Medplus Health Services Ltd. (MEDPLUS) has a ROCE of 22.22%, which is above the benchmark median of 18.08%, a difference of +22.9%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Aditya Vision Ltd. AVL 7,322.77 52.69 9.56 18.55 20.82
Electronics Mart India Ltd. EMIL 7,142.86 33.99 4.01 6.81 11.84
Ethos Ltd. ETHOSLTD 6,860.4 66.33 4.54 7.78 13.7
V-Mart Retail Ltd. VMART 6,385.13 46.4 6.51 14.43 23.56
Redtape Ltd. REDTAPE 6,252.25 25.32 5.85 26.58 31.03

Medplus Health Services Ltd. (MEDPLUS) has a P/E ratio of 34.97x compared with the displayed peer median of 46.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.93% compares with a peer median of 14.43% across the companies shown in the table. ROCE stood at 22.22% versus the displayed peer median of 20.82%, providing a capital-efficiency comparison. Medplus Health Services Ltd. (MEDPLUS) has a market capitalisation of Rs 7,362 crore. It is larger by market capitalisation than all 5 peers shown.

Why Investors Are Watching Medplus Health Services Ltd.

  • MEDPLUS Share Price has touched a fresh 52-week low of Rs 609.25 and is still trading close to that level.
  • MEDPLUS Share Price Today shows a small decline versus the previous close, keeping the stock in focus.
  • MEDPLUS Fundamental Analysis shows PE, PB, ROE, ROCE, EPS and book value that can be compared with retail peers.
  • MEDPLUS Stock News now sits beside a market capitalisation of Rs 7,362 crore, which places the company near the retailing benchmark average.
  • MEDPLUS Share Price also needs to be read with Jun 2026 revenue of Rs 1,879.6 crore and a zero dividend yield.

About Medplus Health Services Ltd.

Medplus Health Services Ltd. operates in retailing. The business is part of the healthcare retail chain space and sits within the broader retailing industry classification used in Univest data. MEDPLUS Share Price reflects a company whose market identity is tied to store-led distribution and consumer-facing sales. The latest Univest figures show Jun 2026 revenue of Rs 1,879.6 crore, which gives a scale reference for the business. MEDPLUS Share Price is therefore not only a market quote; it is tied to a retailing platform with operating metrics that can be compared with other listed retailers.

For MEDPLUS Stock Analysis, the most relevant company details here are sector, industry, valuation and profitability ratios. MEDPLUS Share Price also sits on a book value of Rs 166.52 per share and EPS of 17.52, which help define the accounting and earnings basis behind the stock. Investors tracking MEDPLUS Stock News often look at these business facts alongside the one-year low to understand where the stock stands in the broader retailing universe. Univest keeps these figures together so MEDPLUS Share Price can be followed in one place.

Track MEDPLUS Share Price on Univest

Use Medplus Health Services Ltd. (MEDPLUS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

Track MEDPLUS Share Price on Univest for live price updates, fundamental ratios, 52-week levels, market capitalisation and company insights. MEDPLUS Share Price Today can be followed alongside retail-sector context, valuation metrics and company financials in one place. Univest also keeps MEDPLUS Latest News and MEDPLUS Share News organised for quick reference.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is MEDPLUS Share Price today?

Ans. MEDPLUS Share Price is Rs 611.05. It is trading slightly below the previous close of Rs 612.65 after touching a fresh 52-week low of Rs 609.25 during the current trading session.

Why did MEDPLUS touch a fresh 52-week low?

Ans. The price move is confirmed in Univest data; a company-specific reason has not been established. MEDPLUS Share Price moved to Rs 609.25 intraday and later traded at Rs 611.05. The stock moved -0.26% during the session.

What was MEDPLUS’s previous close?

Ans. The previous close for MEDPLUS Share Price was Rs 612.65. The stock is trading below that level, with a day change of Rs -1.60, or -0.26%, at the latest update.

What is the 52-week low for MEDPLUS?

Ans. MEDPLUS Share Price touched a fresh 52-week low of Rs 609.25. The current price of Rs 611.05 shows the stock is trading just above that one-year trough. The stock moved -0.26% during the session.

What is MEDPLUS’s market capitalisation?

Ans. MEDPLUS Share Price is backed by a market capitalisation of Rs 7,362 crore. That places the company near the average market cap in the retailing benchmark set used by Univest.

How does MEDPLUS compare with retail peers?

Ans. MEDPLUS Share Price has a PE of 34.97 and PB of 3.68. That is below Aditya Vision’s PE and PB, but above Electronics Mart India on PE and below it on PB.

What do MEDPLUS profitability ratios show?

Ans. MEDPLUS Share Price comes with ROE of 11.93% and ROCE of 22.22%. ROCE is above the retailing benchmark median, while ROE is slightly below the benchmark median. ROE stands at 11.93%.

Should investors track MEDPLUS Share Price on Univest?

Ans. MEDPLUS Share Price can be tracked on Univest for live updates, 52-week levels, valuation ratios and retail-sector context. The platform keeps the price move and core fundamentals in one view.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply